Description

This issue of Vital Signs, released on July 17, 2006, provides a strategic overview of the practice of product lifecycle management by pharmaceutical companies to identify new pathways that may be able to increase the revenue upside of a product. Additionally, an emerging company profile is provided on Inspire Pharmaceuticals, an innovative pharmaceutical company with a strong scientific background in ophthalmology, respiratory disease and P2 receptor technology. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of July 5 - July 8, 2006.